2020 Italy Hospital Hemostasis Diagnostics Marke: Supplier Shares and Sales Segment Forecasts

2020 Italy Hospital Hemostasis Diagnostics Marke: Supplier Shares and Sales Segment Forecasts

  • May 2020 •
  • 394 pages •
  • Report ID: 5373000 •
  • Format: PDF
2020 Italy Hospital Hemostasis Diagnostics Marke: Supplier Shares and Sales Segment Forecasts

This new report contains 394 pages, 28 tables, and presents a comprehensive analysis of the Italian hospital hemostasis diagnostic testing market, including: 

  • Major issues pertaining to the Italian coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. 
  • Volume and sales forecasts for 40 coagulation procedures performed in Italian hospitals, including typical coagulation daily work loads. 
  • Review of current instrumentation technologies, and a feature comparison of leading analyzers. 
  • Reagent and instrument sales forecasts.   
  • Sales and market shares of leading reagent and instrument suppliers. 
  • Review of coagulation technologies and their potential market applications. 
  • Major opportunities for coagulation instruments and consumables. 
  • Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in RandD, collaborative arrangements and business strategies. 
  • Business opportunities and strategic recommendations for instrument and reagent
    suppliers. 

        Contains 394 pages and 28 tables

Companies Profiled

Competitive Assessments

Abbott
Accriva
Axis-Shield
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data
Chrono-Log
Corgenix
Diagnostica Stago/Trinity Biotech
Grifols
Helena Laboratories
HYPHEN BioMed
Instrumentation Laboratory/Werfen
Roche
Sekisui Diagnostics
Siemens Healthineers
Sienco
Sysmex
Thermo Fisher